Evaluation of routine biochemical indices and α-fetoprotein versus histology in chronic hepatitis C patients

Arab Journal of Gastroenterology

Volumn 10, Issue 3, 2009, Pages 87-91

  Said, Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Fetoprotein; HCV; Liver fibrosis; Non invasive biochemical indices

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE;

ADULT; AGE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

EID: 70749138683     PISSN: 16871979     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajg.2009.08.002     Document Type: Article

References (13)

1. Strickland G.T., Elhefni H., Salman T., et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67 4 (2002) 436-442
2. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 6 (2003) 1449-1457
3. Rousselet M.C., Michalak S., Dupre F., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 2 (2005) 257-264
4. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 2 (2003) 518-526
5. Rosenberg W.M., Voelker M., Thiel R., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 6 (2004) 1704-1713
6. Bayati N., Silverman A.L., and Gordon S.C. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 93 12 (1998) 2452-2456
7. Chu C.W., Hwang S.J., Luo J.C., et al. Clinical, virologic and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol 32 3 (2001) 240-244
8. Hu K.Q., Kyulo N.L., Lim N., et al. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 99 5 (2004) 860-865
9. Bedossa P., Poynard T., and The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24 2 (1996) 289-293
10. Radhika N.S., Duseja A., Rajwanshi A., et al. Clinico-cytopathological spectrum of hepatocellular carcinoma its correlation with serum alpha-fetoprotein level and hepatitis B and C viral markers. Trop Gastroenterol 25 3 (2004) 116-120
11. Kim B.K., Kim S.A., Park Y.N., et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 27 7 (2007) 969-976
12. Shaheen A.A., and Myers R.P. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review. Hepatology 46 3 (2007) 912-921
13. Poynard T., and Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR cooperative study groups. J Viral Hepat 4 3 (1997) 199-208